Patent ID: 11945851
Assignee: THE WISTAR INSTITUTE OF ANATOMY AND BIOLOGY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 2:
3. The immunological composition of claim 2, wherein the one or more additional cancer antigens comprise one or more antigens selected from the group consisting of the amino acid sequence of tyrosinase (Tyr), the amino acid sequence of tyrosinase-related protein 1 (TYRP1), the amino acid sequence of tyrosinase-related protein 2 (TYRP2), the amino acid sequence of hTERT, the amino acid sequence of growth hormone release hormone (GHRH), the amino acid sequence of MART-1/melan-A antigen (MART-1/Melan-A), the amino acid sequence of cancer testis antigen (NY-ESO-1), the amino acid sequence of cancer testis antigen II (NY-ESO-2), the amino acid sequence of PRAME, the amino acid sequence of WT1, the amino acid sequence of PSA, the amino acid sequence of PSMA, the amino acid sequence of STEAP, the amino acid sequence of PSCA, the amino acid sequence of gp100, the amino acid sequence of a viral antigen, and a combination thereof.